Search

The Centers for Medicare & Medicaid Services created the Cell and Gene Therapy Access Model to be able to negotiate with manufacturers on behalf of states to make high-cost specialty drugs available to beneficiaries and affordable to State Medicaid Agencies. 

The nation’s ability to identify and respond to outbreaks relies on access to high-quality and timely data for disease surveillance.

Improving healthcare quality while reducing costs is a goal Abt Global has been helping the Centers for Medicare and Medicaid Services (CMS) pursue for more than a decade through evaluations and more. CMS’s Integrated Care for Kids (InCK) payment and…

Many medium and large cities in developing countries lack the capacity to adequately manage solid waste. Limited awareness of best practices for waste management and lack of access to key technical resources are key barriers to improvement. 

Through EvidenceNOW, we have new insights on effective strategies to support and strengthen the essential work of primary care.

Artificial intelligence (AI) is reshaping how we live, work, and interact with technology. As AI’s capabilities expand, so do its ethical and societal implications. In this master class, Dr. Nora Connor, Abt Global’s director of data science and AI, explores how AI evolved and how we can ensure its use for good.

This brief by Abt Global discusses a preferred tools for processing large amounts of information in 21st century knowledge curation.

For more than 35 years, Abt has delivered extensive regulatory support services to state and federal clients, including the Environmental Protection Agency, Department of Transportation, Department of Health and Human Services, Department of the Interior, Coast Guard, and Occupational Safety and Health Administration.